Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKEJA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,394
Award facts
- Contract value 100% obligated
- $28,393.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,393.50 to DMS Pharmaceutical Group Inc. for NUCALA 100 mg/mL syringes. The award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. This delivery order was not subject to a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor and will perform the work at its location in Park Ridge, Illinois.
This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company holds a significant single-award IDC with DLA valued at $499,999,999 through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide. NUCALA, a specialty pharmaceutical injection, aligns with DMS Pharmaceutical Group's portfolio of delivering biologics and specialty medications to Department of Defense healthcare sites. The rapid completion timeline reflects the standard operational approach for pharmaceutical supply deliveries to federal agencies.
Quick answers
Who was awarded contract SPE2DB25FKEJA?
SPE2DB25FKEJA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FKEJA worth?
The government has obligated $28,394 on SPE2DB25FKEJA.
Is contract SPE2DB25FKEJA an order under another contract?
Yes. SPE2DB25FKEJA is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEJA competed?
The extent of competition for SPE2DB25FKEJA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award